International Advocacy Reach With over 400 members across 25 countries, the Alliance for Regenerative Medicine offers a significant network of biotech companies, academic institutions, and patient organizations, providing excellent opportunities for partnerships, collaborations, and outreach in the regenerative medicine sector.

Growing Sector Reports Recent sector snapshot and workforce analysis reports highlight the sector’s impressive growth and development, indicating increasing investment and interest that could lead to expanded adoption of new therapeutic technologies and services.

Policy and Regulatory Engagement ARM’s active involvement in policy advocacy and collaborations, such as the joint call for a moratorium on heritable genome editing, positions it as a key influencer, opening doors for partnerships around compliance, regulatory consulting, and policy-driven solutions.

Industry Events and Initiatives Participation in high-profile events like the Cell & Gene Meeting signifies ongoing industry momentum and provides opportunities to connect with key stakeholders, investors, and innovators in cutting-edge cell and gene therapies.

Expanding Leadership and Partnerships Recent hires and collaborations, including engaging with organizations like Veristat and partnerships with ISCT, demonstrate ARM’s expanding influence and open channels for service expansion in clinical development, reimbursement, and sector-specific consultancy.